HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Sparfloxacin (Sparflo) in the treatment of urological infections].

Abstract
Sparfloxacin efficacy evaluation for the treatment of urogenital tract infections is presented. The trial was performed on 43 patients with chronic complicated infections of urogenital tract (pyelonephritis, prostatitis). Sparfloxacin (once daily for 7-14 days) was highly effective in the infection management according to clinical and bacteriological results (83.7 per cent and 78.1 per cent subsequently).
AuthorsN A Lopatkin, I I Derevianko, L N Lavrinova, L A Nefedova
JournalAntibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] (Antibiot Khimioter) Vol. 47 Issue 1 Pg. 18-20 ( 2002) ISSN: 0235-2990 [Print] Russia (Federation)
Vernacular TitleSparfloksatsin (sparflo) pri lechenii infektsiĭ v urologii.
PMID12077935 (Publication Type: Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Fluoroquinolones
  • sparfloxacin
Topics
  • Anti-Infective Agents (therapeutic use)
  • Chronic Disease
  • Fluoroquinolones
  • Humans
  • Male
  • Prostatitis (drug therapy)
  • Pyelonephritis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: